Influenza VLP Vaccine

BIOLOGICAL2 trials

Sponsors

Novavax

Conditions

InfluenzaSeasonal Influenza

Phase 2

Trial to Evaluate Safety and Immunogenicity of Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant)

CompletedNCT00903552

NovavaxSeasonal Influenza

Start: 2009-05-31End: 2009-10-31Updated: 2013-07-18

Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults

CompletedNCT01014806

NovavaxInfluenza

Start: 2009-11-30End: 2010-05-31Updated: 2013-07-18